Olugbenga S Michael1,2,3, Lawrence A Olatunji1,2. 1. a Cardiovascular Research Laboratory, Department of Physiology , University of Ilorin, Ilorin, Nigeria. 2. b Hope Cardiometabolic Research Centre , Ilorin , Nigeria. 3. c Cardiometabolic Research Unit, Department of Physiology , College of Health sciences, Bowen University , Iwo , Nigeria.
Abstract
CONTEXT: Cigarette smoking is considered to be a major risk factor for the development of diabetes and cardiovascular disease. Oestrogen-progestin combined oral contraceptive (COC) use has been associated with adverse cardiometabolic events. OBJECTIVE: We hypothesized that nicotine would ameliorate insulin resistance (IR) that is accompanied by decreased cardiac glycogen synthase kinase-3 (GSK-3) and plasminogen activator inhibitor-1 (PAI-1). METHODS: Female Wistar rats received (po) low-(0.1 mg/kg) or high-nicotine (1.0 mg/kg) with or without COC containing 5.0 µg levonorgestrel plus 1.0 µg ethinylestradiol daily for 8 weeks. RESULTS: Data showed that COC treatment or nicotine exposure led to IR, glucose deregulation, atherogenic dyslipidemia, increased corticosterone, aldosterone, cardiac and circulating GSK-3 values and PAI-1. However, these effects with the exception of corticosterone and aldosterone were ameliorated in COC + nicotine-exposed rats. CONCLUSION: Amelioration of IR induced by COC treatment is accompanied by decreased circulating PAI-1, cardiac PAI-1 and GSK-3 instead of circulating aldosterone and corticosterone.
CONTEXT: Cigarette smoking is considered to be a major risk factor for the development of diabetes and cardiovascular disease. Oestrogen-progestin combined oral contraceptive (COC) use has been associated with adverse cardiometabolic events. OBJECTIVE: We hypothesized that nicotine would ameliorate insulin resistance (IR) that is accompanied by decreased cardiac glycogen synthase kinase-3 (GSK-3) and plasminogen activator inhibitor-1 (PAI-1). METHODS: Female Wistar rats received (po) low-(0.1 mg/kg) or high-nicotine (1.0 mg/kg) with or without COC containing 5.0 µg levonorgestrel plus 1.0 µg ethinylestradiol daily for 8 weeks. RESULTS: Data showed that COC treatment or nicotine exposure led to IR, glucose deregulation, atherogenic dyslipidemia, increased corticosterone, aldosterone, cardiac and circulating GSK-3 values and PAI-1. However, these effects with the exception of corticosterone and aldosterone were ameliorated in COC + nicotine-exposed rats. CONCLUSION: Amelioration of IR induced by COC treatment is accompanied by decreased circulating PAI-1, cardiac PAI-1 and GSK-3 instead of circulating aldosterone and corticosterone.
Authors: Gaber El-Saber Batiha; Hayder M Al-Kuraishy; Thabat J Al-Maiahy; Ali K Al-Buhadily; Hebatallah M Saad; Ali I Al-Gareeb; Jesus Simal-Gandara Journal: Diabetol Metab Syndr Date: 2022-09-08 Impact factor: 5.395
Authors: Olufunto O Badmus; Emmanuel D Areola; Eleojo Benjamin; Matthew A Obekpa; Tolulope E Adegoke; Oluwatobi E Elijah; Aminu Imam; Olayemi J Olajide; Lawrence A Olatunji Journal: J Renin Angiotensin Aldosterone Syst Date: 2021-05-18 Impact factor: 1.636
Authors: Igor Fernando de Aquino Moreira; Maria Passos Bianchini; Gabrielle Rodrigues Campos Moreira; Alessandra Maciel Almeida; Bruno Almeida Rezende Journal: BMC Womens Health Date: 2020-10-27 Impact factor: 2.809